a gene editing programme for treating chronic Hepatitis B patients who are HBeAg-negative. In cohort one, the lowest dose level of PBGENE-HBV was administered to three subjects at a dose of 0.2mg ...

The ELIMINATE-B study is currently enrolling HBeAg-negative chronic Hepatitis ... to provide additional administrations at this dose level and subsequently plans to escalate to higher dose levels ...